{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:10:00Z","timestamp":1768637400824,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"26","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.vaccine.2020.04.024","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T08:14:50Z","timestamp":1588580090000},"page":"4200-4208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Measles and rubella IgG seroprevalence in persons 6\u00a0month-35\u00a0years of age, Mongolia, 2016"],"prefix":"10.1016","volume":"38","author":[{"given":"Francisco","family":"Nogareda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nyamaa","family":"Gunregjav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amarzaya","family":"Sarankhuu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkhtuya","family":"Munkhbat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enkhbaatar","family":"Ichinnorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pagbajabyn","family":"Nymadawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathleen","family":"Wannemuehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mick N.","family":"Mulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose","family":"Hagan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minal K.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2020.04.024_b0005","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.jviromet.2007.08.021","article-title":"An indirect immunocolorimetric assay to detect rubella virus infected cells","volume":"146","author":"Chen","year":"2007","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.04.024_b0010","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1128\/CVI.00681-13","article-title":"High-throughput assay optimization and statistical interpolation of rubella-specific neutralizing antibody titers","volume":"21","author":"Lambert","year":"2014","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2020.04.024_b0015","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.jviromet.2005.08.001","article-title":"Measles immunity testing: comparison of two measles IgG ELISAs with plaque reduction neutralisation assay","volume":"131","author":"Cohen","year":"2006","journal-title":"J Virol Methods"},{"key":"10.1016\/j.vaccine.2020.04.024_b0020","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1093\/ajcp\/106.2.170","article-title":"Rubella immunity. Defining the level of protective antibody","volume":"106","author":"Skendzel","year":"1996","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.vaccine.2020.04.024_b0025","unstructured":"World Health Organization. Guidelines on the use of serosurveys in support of measles and rubella elimination. Geneva, Switzerland: Immunizations, Vaccines, and Biologicals; 2019. https:\/\/www.who.int\/immunization\/monitoring_surveillance\/burden\/laboratory\/serosurvey\/en\/. Accessed: December 13, 2019."},{"key":"10.1016\/j.vaccine.2020.04.024_b0030","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1016\/j.vaccine.2016.06.006","article-title":"A review of testing used in seroprevalence studies on measles and rubella","volume":"34","author":"Dimech","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0035","unstructured":"Framework for verifying elimination of measles and rubella. Wkly Epidemiol Rec 2013; 88: 89\u201399."},{"key":"10.1016\/j.vaccine.2020.04.024_b0040","unstructured":"World Health Organization Regional Office for the Western Pacific. Mongolia certified measles free. 2014. http:\/\/www.wpro.who.int\/mediacentre\/releases\/2014\/20140708\/en\/. Accessed: April 4, 2018."},{"key":"10.1016\/j.vaccine.2020.04.024_b0045","doi-asserted-by":"crossref","first-page":"198","DOI":"10.7883\/yoken.JJID.2007.198","article-title":"Measles outbreak after a post-honeymoon period in Mongolia, 2001","volume":"60","author":"Rentsen","year":"2007","journal-title":"Jpn J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.024_b0050","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1186\/s12889-019-6511-0","article-title":"Epidemiological characteristics and trends of a Nationwide measles outbreak in Mongolia, 2015\u20132016","volume":"19","author":"Orsoo","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/j.vaccine.2020.04.024_b0055","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1093\/infdis\/jix449","article-title":"Risk factors for measles virus infection among adults during a large outbreak in postelimination era in Mongolia, 2015","volume":"216","author":"Hagan","year":"2017","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.024_b0060","doi-asserted-by":"crossref","first-page":"6463","DOI":"10.1016\/j.vaccine.2019.08.085","article-title":"Measles and rubella immunity in the population of Bhutan, 2017","volume":"37","author":"Wangchuk","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0065","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/tmi.12737","article-title":"Seroepidemiology: an underused tool for designing and monitoring vaccination programmes in low- and middle-income countries","volume":"21","author":"Cutts","year":"2016","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.vaccine.2020.04.024_b0070","doi-asserted-by":"crossref","first-page":"4001","DOI":"10.1016\/j.vaccine.2018.04.036","article-title":"Assessing population immunity for measles elimination - The promise and peril of serosurveys","volume":"36","author":"Durrheim","year":"2018","journal-title":"Vaccine"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.04.024_b0075","first-page":"S27","article-title":"The theory of measles elimination: implications for the design of elimination strategies","volume":"189","author":"Gay","year":"2004","journal-title":"J Infect Dis"},{"issue":"Suppl 1","key":"10.1016\/j.vaccine.2020.04.024_b0080","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1093\/infdis\/jir065","article-title":"Biological feasibility of measles eradication","volume":"204","author":"Moss","year":"2011","journal-title":"J Infect Dis"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2020.04.024_b0085","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.1016\/S0264-410X(99)00290-X","article-title":"The immunization system in the United States - the role of school immunization laws","volume":"17","author":"Orenstein","year":"1999","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0090","doi-asserted-by":"crossref","first-page":"457","DOI":"10.2105\/AJPH.66.5.457","article-title":"An evaluation of three techniques improving immunization levels in elementary schools","volume":"66","author":"Vernon","year":"1976","journal-title":"Am J Public Health"},{"key":"10.1016\/j.vaccine.2020.04.024_b0095","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1080\/14760584.2017.1393337","article-title":"Measles and rubella elimination: learning from polio eradication and moving forward with a diagonal approach","volume":"16","author":"Goodson","year":"2017","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.vaccine.2020.04.024_b0100","doi-asserted-by":"crossref","first-page":"2050","DOI":"10.1016\/j.vaccine.2015.02.078","article-title":"Accelerating measles elimination and strengthening routine immunization services in Guizhou Province, China, 2003\u20132009","volume":"33","author":"Zuo","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0105","unstructured":"National Statistics Office of Mongolia. 2015 population and housing by-census of Mongolia: National Report. Ulaanbaatar 2016. http:\/\/www.en.nso.mn\/content\/166. Accessed: July 3, 2018."},{"key":"10.1016\/j.vaccine.2020.04.024_b0110","doi-asserted-by":"crossref","first-page":"217","DOI":"10.11604\/pamj.2017.26.217.11856","article-title":"Maternal education and child immunization: the mediating roles of maternal literacy and socioeconomic status","volume":"26","author":"Balogun","year":"2017","journal-title":"Pan Afr Med J"},{"key":"10.1016\/j.vaccine.2020.04.024_b0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1186\/s12879-017-2890-y","article-title":"The global effect of maternal education on complete childhood vaccination: a systematic review and meta-analysis","volume":"17","author":"Forshaw","year":"2017","journal-title":"BMC Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.024_b0120","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013853","article-title":"Maternal education, empowerment, economic status and child polio vaccination uptake in Pakistan: a population based cross sectional study","volume":"7","author":"Khan","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.vaccine.2020.04.024_b0125","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.socscimed.2012.02.043","article-title":"Linkages between maternal education and childhood immunization in India","volume":"75","author":"Vikram","year":"2012","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.vaccine.2020.04.024_b0130","first-page":"157","article-title":"Evaluation of a mass measles immunisation campaign in a rapidly growing peri-urban area","volume":"76","author":"Kearney","year":"1989","journal-title":"South African Medical Journal = Suid-Afrikaanse tydskrif vir geneeskunde"},{"key":"10.1016\/j.vaccine.2020.04.024_b0135","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.vaccine.2017.10.080","article-title":"Impact of measles supplementary immunization activities on reaching children missed by routine programs","volume":"36","author":"Portnoy","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.healthpol.2006.11.008","article-title":"Measles supplemental immunization activities improve measles vaccine coverage and equity: Evidence from Kenya, 2002","volume":"83","author":"Vijayaraghavan","year":"2007","journal-title":"Health Policy (Amsterdam, Netherlands)."},{"key":"10.1016\/j.vaccine.2020.04.024_b0145","doi-asserted-by":"crossref","first-page":"5721","DOI":"10.1016\/j.vaccine.2012.07.007","article-title":"Gaps in the 2010 measles SIA coverage among migrant children in Beijing: evidence from a parental survey","volume":"30","author":"Hu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2020.04.024_b0150","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/infdis\/162.5.1036","article-title":"Measles antibody: reevaluation of protective titers","volume":"162","author":"Chen","year":"1990","journal-title":"J Infect Dis"},{"key":"10.1016\/j.vaccine.2020.04.024_b0155","unstructured":"World Health Organization. WHO vaccine-preventable diseases: monitoring system. 2019 global summary. 2019. http:\/\/apps.who.int\/immunization_monitoring\/globalsummary\/countries?countrycriteria%5Bcountry%5D%5B%5D=MNG. Accessed: October 7, 2019."}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X20305041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:43:24Z","timestamp":1759401804000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X20305041"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":31,"journal-issue":{"issue":"26","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S0264410X20305041"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.024","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measles and rubella IgG seroprevalence in persons 6\u00a0month-35\u00a0years of age, Mongolia, 2016","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2020.04.024","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}